Basilea Pharmaceutica to get $1.25m license fee from Pfizer
Switzerland’s Basilea Pharmaceutica Ltd. will receive $1.25 million from its partner Pfizer Inc. after the latter exceeded the sales target for a licensed.
Bharti Rana Jayshankar – Founder
She brings in more than 30 years of experience in content building, architecture, writing, editing and storytelling. Ms Jayshankar has worked in the Economic Times daily, IBT Times, Investopedia and more than a dozen content firms as a content strategist and planner.
Jay Shankar – Co-founder
He has almost three decades of experience in journalism. He has worked with national dailies such as ET, Indian Express, The Pioneer, The Hindu, Agence France Presse and Bloomberg.
Switzerland’s Basilea Pharmaceutica Ltd. will receive $1.25 million from its partner Pfizer Inc. after the latter exceeded the sales target for a licensed.
China’s drug regulator, the National Medical Products Association, has approved AstraZeneca Plc’s asthma drug.
HQ Team May 17, 2024: A measles vaccine given to a child born by caesarean section is likely to be 2.6 times completely.
HQ Team April 20, 2024: Forty-five percent of 82 urban areas in China, with a total population of about 700 million, are sinking.
By K. Leelamoni November 5, 2023: Outbreaks of pneumonia affecting children in parts of northern China, the US, the Netherlands, and Denmark are higher than.
HQ Team December 1, 2023: The US Food and Drug Administration (USFDA) is assessing the potential for failures in plastic syringes manufactured in.
HQ Team November 28, 2023: The USFDA has officially pulled out of its membership of the Global Harmonization Working Party (GHWP), an organization.
The World Health Organization is monitoring an increase in children’s illness caused by pathogens, including acute respiratory syndrome coronavirus 2, in northern China.
HQ Team October 12, 2023: An estimated five billion people will face inadequate access to water at least a month, every year by.
HQ Team October 10, 2023: US and Chinese researchers have developed an artificial intelligence-based platform to predict earthquakes with 70% accuracy. The AI.
We use cookies to improve your experience on our site. By using our site, you consent to cookies.
Manage your cookie preferences below:
Essential cookies enable basic functions and are necessary for the proper function of the website.
Statistics cookies collect information anonymously. This information helps us understand how visitors use our website.
Google Analytics is a powerful tool that tracks and analyzes website traffic for informed marketing decisions.
Service URL: policies.google.com